AP3140A - Production of polio virus at high titers for vaccine production - Google Patents

Production of polio virus at high titers for vaccine production

Info

Publication number: AP3140A
Authority: AP; ARIPO
Prior art keywords: production; high titers; polio virus; vaccine; vaccine production
Prior art date: 2009-07-16

Application number

AP2012006075A

Other languages

English (en)

Other versions

AP2012006075A0 (en

Inventor

John Alfred Lewis

Original Assignee

Crucell Holland Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-07-16

Filing date

2010-07-08

Publication date

2015-02-28

2010-07-08 Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv

2012-02-29 Publication of AP2012006075A0 publication Critical patent/AP2012006075A0/xx

2015-02-28 Application granted granted Critical

2015-02-28 Publication of AP3140A publication Critical patent/AP3140A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AP2012006075A 2009-07-16 2010-07-08 Production of polio virus at high titers for vaccine production AP3140A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27103809P	2009-07-16	2009-07-16
EP09165620		2009-07-16
PCT/EP2010/059796 WO2011006823A1 (en)	2009-07-16	2010-07-08	Production of polio virus at high titers for vaccine production

Publications (2)

Publication Number	Publication Date
AP2012006075A0 AP2012006075A0 (en)	2012-02-29
AP3140A true AP3140A (en)	2015-02-28

Family

ID=41412431

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2012006075A AP3140A (en)	2009-07-16	2010-07-08	Production of polio virus at high titers for vaccine production

Country Status (32)

Country	Link
US (4)	US8546123B2 (es)
EP (1)	EP2454364B1 (es)
JP (1)	JP5845178B2 (es)
KR (1)	KR101548790B1 (es)
CN (1)	CN102482647B (es)
AP (1)	AP3140A (es)
AR (1)	AR077314A1 (es)
AU (1)	AU2010272685B2 (es)
BR (1)	BR112012000942B8 (es)
CA (1)	CA2763091C (es)
CO (1)	CO6491042A2 (es)
CU (1)	CU20120006A7 (es)
DK (1)	DK2454364T3 (es)
EA (1)	EA020563B1 (es)
ES (1)	ES2484093T3 (es)
HR (1)	HRP20140597T1 (es)
IL (1)	IL217465A (es)
MA (1)	MA33429B1 (es)
MX (1)	MX2011012648A (es)
MY (1)	MY183385A (es)
NZ (1)	NZ596880A (es)
PE (1)	PE20120571A1 (es)
PL (1)	PL2454364T3 (es)
PT (1)	PT2454364E (es)
RS (1)	RS53377B (es)
SG (1)	SG177655A1 (es)
SI (1)	SI2454364T1 (es)
SM (1)	SMT201400079B (es)
TN (1)	TN2011000628A1 (es)
TW (1)	TWI477606B (es)
WO (1)	WO2011006823A1 (es)
ZA (1)	ZA201108271B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007126810A2 (en)	2006-03-31	2007-11-08	Warf - Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses for vaccines
WO2008156778A2 (en)	2007-06-18	2008-12-24	Tokiko Watanabe	Influenza m2 protein mutant viruses as live influenza attenuated vaccines
NZ593235A (en)	2008-11-03	2013-02-22	Crucell Holland Bv	Method for the production of recombinant adenovirus serotype 35
MA33429B1 (fr) *	2009-07-16	2012-07-03	Crucell Holland Bv	Production de poliovirus à titres élevés pour la production de vaccins
JP2013507990A (ja)	2009-10-26	2013-03-07	ダブリュエーアールエフ−ウィスコンシンアラムナイリサーチファウンデーション	ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
US10130697B2 (en)	2010-03-23	2018-11-20	Wisconsin Alumni Research Foundation (Warf)	Vaccines comprising mutant attenuated influenza viruses
JP2014527799A (ja)	2011-08-26	2014-10-23	ダブリュエーアールエフ−ウィスコンシンアラムナイリサーチファウンデーション	変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
BR112015018493A2 (pt) *	2013-02-05	2017-08-22	Univ Georgia	Linhagens celulares para produção de vírus e métodos de uso
KR102236498B1 (ko)	2013-03-08	2021-04-06	얀센 백신스 앤드 프리벤션 비.브이.	무세포 백일해 백신
WO2014142433A1 (ko)	2013-03-13	2014-09-18	고려대학교산학협력단	바이러스 생산능이 증가된 세포주 및 그 제조방법
KR20140112255A (ko)	2013-03-13	2014-09-23	고려대학교 산학협력단	바이러스 생산능이 증가된 세포주 및 그 제조방법
GB201305361D0 (en)	2013-03-25	2013-05-08	Univ Edinburgh	Enhanced expression
ES2689150T3 (es)	2013-06-17	2018-11-08	De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport	Métodos para la prevención de agregación de componentes víricos
US9950057B2 (en)	2013-07-15	2018-04-24	Wisconsin Alumni Research Foundation (Warf)	High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
US20160053281A1 (en) *	2013-08-15	2016-02-25	The University Court Of The University Of Edinburgh	Enhanced Expression Of RNA Vectors
EP3613841B1 (en)	2014-03-25	2022-04-20	Terumo BCT, Inc.	Passive replacement of media
KR102423993B1 (ko)	2014-06-17	2022-07-22	얀센 백신스 앤드 프리벤션 비.브이.	저온-적응-바이러스-약독화(cava) 및 신규의 약독화 폴리오바이러스 균주
JP6708636B2 (ja)	2014-06-18	2020-06-10	イミュノマックスカンパニーリミテッドＩｍｍｕｎｏｍａｘＣｏ．，Ｌｔｄ．	Ｂｓｔ２遺伝子の機能が喪失された細胞株を利用したウィルス感染促進及び産生増進方法
US10053671B2 (en)	2014-06-20	2018-08-21	Wisconsin Alumni Research Foundation (Warf)	Mutations that confer genetic stability to additional genes in influenza viruses
DK3172317T3 (da)	2014-07-24	2019-07-22	Janssen Vaccines & Prevention Bv	Fremgangsmåde til oprensning af poliovirus fra cellekulturer
US10633422B2 (en)	2015-06-01	2020-04-28	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
WO2017004592A1 (en)	2015-07-02	2017-01-05	Terumo Bct, Inc.	Cell growth with mechanical stimuli
US9890363B2 (en)	2015-07-06	2018-02-13	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication for vaccine development
WO2017143236A1 (en)	2016-02-19	2017-08-24	Yoshihiro Kawaoka	Improved influenza b virus replication for vaccine development
CN109415696A (zh)	2016-05-25	2019-03-01	泰尔茂比司特公司	细胞扩增
US11685883B2 (en)	2016-06-07	2023-06-27	Terumo Bct, Inc.	Methods and systems for coating a cell growth surface
US11104874B2 (en)	2016-06-07	2021-08-31	Terumo Bct, Inc.	Coating a bioreactor
US10372100B2 (en) *	2016-08-29	2019-08-06	Ge Healthcare Bio-Sciences Corp.	Manufacturing system for biopharmaceutical products
CN110612344B (zh)	2017-03-31	2023-09-12	泰尔茂比司特公司	细胞扩增
CN107723279B (zh) *	2017-10-18	2020-11-10	成都远睿生物技术有限公司	一种缺陷型腺病毒AdC68-GP的培养方法
JP2021500891A (ja)	2017-10-25	2021-01-14	ウィスコンシンアルムニリサーチファンデイション	卵における複製のための安定化されたｈａを有する組換えインフルエンザウイルス
SG11202007503WA (en)	2018-02-07	2020-09-29	Bharat Biotech Int Ltd	A process for enterovirus purification and inactivation and vaccine compositions obtained thereof
JP7783047B2 (ja)	2018-08-07	2025-12-09	ウィスコンシンアルムニリサーチファンデイション	組換えの生物学的に封じ込められたフィロウイルスワクチン
US11389523B2 (en)	2018-08-20	2022-07-19	Wisconsin Alumni Research Foundation (Warf)	Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
EP3914295A2 (en)	2019-01-23	2021-12-01	Yoshihiro Kawaoka	Mutations that confer genetic stability to additional genes in influenza viruses
CN113874496A (zh)	2019-02-08	2021-12-31	威斯康星校友研究基金会(Warf)	人源化细胞系
US11390649B2 (en)	2019-05-01	2022-07-19	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication for vaccine development
EP3969046A1 (en)	2019-05-16	2022-03-23	Janssen Vaccines & Prevention B.V.	Methods for inducing a safe immune response against polio virus
JP7627911B2 (ja)	2019-08-27	2025-02-07	ウィスコンシンアルムニリサーチファンデイション	卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
JP2023511444A (ja)	2020-01-24	2023-03-17	ウィスコンシンアルムニリサーチファンデイション	安定化されたｎａを有する組換えインフルエンザウイルス
WO2021195410A1 (en)	2020-03-25	2021-09-30	Wisconsin Alumni Research Foundation (Warf)	Recombinant multivalent influenza viruses

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4525349A (en) *	1981-12-29	1985-06-25	Societe Anonyme Dite: Institut Merueux	Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine
DE69633565T3 (de)	1995-06-15	2013-01-17	Crucell Holland B.V.	Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
EP1103610A1 (en) *	1999-11-26	2001-05-30	Introgene B.V.	Production of vaccines from immortalised mammalian cell lines
US7521220B2 (en)	1999-11-26	2009-04-21	Crucell Holland B.V.	Production of vaccines
US6544424B1 (en)	1999-12-03	2003-04-08	Refined Technology Company	Fluid filtration system
EP1256803A1 (en)	2001-05-07	2002-11-13	Crucell Holland B.V.	Methods for the identification of antiviral compounds
WO2004037294A2 (en)	2002-10-23	2004-05-06	Crucell Holland B.V.	New settings for recombinant adenoviral-based vaccines
CA2507915C (en)	2002-12-17	2013-07-02	Crucell Holland B.V.	Recombinant viral-based malaria vaccines
BRPI0409895B8 (pt)	2003-05-09	2021-05-25	Crucell Holland Bv	método de cultura de células derivadas de células per.c6 capazes de crescer em suspensão para aumentar o rendimento de produto das referidas células
CN104388324A (zh)	2004-03-05	2015-03-04	帝斯曼知识产权资产管理有限公司	用于通过连续灌注和交互切向流来培养细胞的方法
WO2007007344A1 (en)	2004-08-27	2007-01-18	Panacea Biotec Ltd.	Inactivated poliomyelitis vaccine derived from sabin strain of polio virus
NZ583291A (en)	2004-10-14	2011-06-30	Glaxosmithkline Biolog Sa	Malaria prime/boost vaccines using adenoviral vectors and adjuvated proteins
CN100500827C (zh) *	2004-11-26	2009-06-17	中国医学科学院医学生物学研究所	用人胚肺二倍体细胞培养繁殖脊髓灰质炎病毒的方法
EP2081589B1 (en)	2006-11-16	2010-10-06	Crucell Holland B.V.	Complementation of factor xi deficiency by factor v mutants
MA33429B1 (fr) *	2009-07-16	2012-07-03	Crucell Holland Bv	Production de poliovirus à titres élevés pour la production de vaccins
KR20120070015A (ko)	2010-12-21	2012-06-29	(주)창조바이오텍	알파-피넨을 유효성분으로 포함하는 스쿠티카충 구제용 조성물

2010
- 2010-07-08 MA MA34534A patent/MA33429B1/fr unknown
- 2010-07-08 MX MX2011012648A patent/MX2011012648A/es active IP Right Grant
- 2010-07-08 PT PT107298952T patent/PT2454364E/pt unknown
- 2010-07-08 BR BR112012000942A patent/BR112012000942B8/pt not_active IP Right Cessation
- 2010-07-08 EP EP10729895.2A patent/EP2454364B1/en active Active
- 2010-07-08 JP JP2012519981A patent/JP5845178B2/ja not_active Expired - Fee Related
- 2010-07-08 DK DK10729895.2T patent/DK2454364T3/da active
- 2010-07-08 CN CN201080026814.2A patent/CN102482647B/zh not_active Expired - Fee Related
- 2010-07-08 RS RS20140325A patent/RS53377B/sr unknown
- 2010-07-08 KR KR1020127001501A patent/KR101548790B1/ko not_active Expired - Fee Related
- 2010-07-08 ES ES10729895.2T patent/ES2484093T3/es active Active
- 2010-07-08 PE PE2012000051A patent/PE20120571A1/es active IP Right Grant
- 2010-07-08 HR HRP20140597AT patent/HRP20140597T1/hr unknown
- 2010-07-08 WO PCT/EP2010/059796 patent/WO2011006823A1/en not_active Ceased
- 2010-07-08 AU AU2010272685A patent/AU2010272685B2/en not_active Ceased
- 2010-07-08 AP AP2012006075A patent/AP3140A/xx active
- 2010-07-08 SI SI201030661T patent/SI2454364T1/sl unknown
- 2010-07-08 MY MYPI2012000173A patent/MY183385A/en unknown
- 2010-07-08 NZ NZ596880A patent/NZ596880A/xx not_active IP Right Cessation
- 2010-07-08 EA EA201270173A patent/EA020563B1/ru not_active IP Right Cessation
- 2010-07-08 SG SG2012002705A patent/SG177655A1/en unknown
- 2010-07-08 CA CA2763091A patent/CA2763091C/en active Active
- 2010-07-08 PL PL10729895T patent/PL2454364T3/pl unknown
- 2010-07-14 AR ARP100102556A patent/AR077314A1/es active IP Right Grant
- 2010-07-15 TW TW099123327A patent/TWI477606B/zh not_active IP Right Cessation
- 2010-07-16 US US12/804,242 patent/US8546123B2/en not_active Expired - Fee Related
2011
- 2011-11-10 ZA ZA2011/08271A patent/ZA201108271B/en unknown
- 2011-12-07 TN TNP2011000628A patent/TN2011000628A1/en unknown
2012
- 2012-01-10 IL IL217465A patent/IL217465A/en active IP Right Grant
- 2012-01-13 CU CU2012000006A patent/CU20120006A7/es unknown
- 2012-01-16 CO CO12005515A patent/CO6491042A2/es unknown
- 2012-10-25 US US13/660,412 patent/US20130052224A1/en not_active Abandoned
2013
- 2013-03-15 US US13/843,052 patent/US20130273106A1/en not_active Abandoned
2014
- 2014-05-12 US US14/275,392 patent/US9022240B2/en active Active
- 2014-06-24 SM SM201400079T patent/SMT201400079B/xx unknown

Also Published As

Publication number	Publication date
AU2010272685A1 (en)	2011-12-08
CU20120006A7 (es)	2012-10-15
SI2454364T1 (sl)	2014-08-29
US20140242670A1 (en)	2014-08-28
TW201118173A (en)	2011-06-01
AU2010272685B2 (en)	2015-02-26
CO6491042A2 (es)	2012-07-31
CA2763091C (en)	2019-07-23
SMT201400079B (it)	2014-09-08
ZA201108271B (en)	2012-07-25
MA33429B1 (fr)	2012-07-03
US8546123B2 (en)	2013-10-01
CA2763091A1 (en)	2011-01-20
TWI477606B (zh)	2015-03-21
JP5845178B2 (ja)	2016-01-20
HRP20140597T1 (hr)	2014-09-12
US20110027317A1 (en)	2011-02-03
PE20120571A1 (es)	2012-06-06
PT2454364E (pt)	2014-07-04
CN102482647B (zh)	2015-12-16
BR112012000942A2 (pt)	2016-03-15
DK2454364T3 (da)	2014-07-21
EA020563B1 (ru)	2014-12-30
KR101548790B1 (ko)	2015-08-31
RS53377B (sr)	2014-10-31
US20130052224A1 (en)	2013-02-28
IL217465A (en)	2016-05-31
US20130273106A1 (en)	2013-10-17
AP2012006075A0 (en)	2012-02-29
BR112012000942B1 (pt)	2020-10-27
US9022240B2 (en)	2015-05-05
JP2012532616A (ja)	2012-12-20
EP2454364A1 (en)	2012-05-23
PL2454364T3 (pl)	2014-09-30
SG177655A1 (en)	2012-02-28
ES2484093T3 (es)	2014-08-11
HK1164922A1 (en)	2012-09-28
TN2011000628A1 (en)	2013-05-24
IL217465A0 (en)	2012-02-29
EA201270173A1 (ru)	2012-06-29
BR112012000942B8 (pt)	2021-05-25
AR077314A1 (es)	2011-08-17
NZ596880A (en)	2013-10-25
CN102482647A (zh)	2012-05-30
KR20120033334A (ko)	2012-04-06
WO2011006823A1 (en)	2011-01-20
MX2011012648A (es)	2012-01-12
MY183385A (en)	2021-02-18
EP2454364B1 (en)	2014-04-23

Publication	Publication Date	Title
AP3140A (en)	2015-02-28	Production of polio virus at high titers for vaccine production
ZA201202836B (en)	2012-12-27	Method of preparing plant-derived vlps
HUS1700002I1 (hu)	2017-02-28	Hepatitis C vírus replikációjának inhibitorai
ZA201202758B (en)	2013-06-26	Stabilising excipient for inactivated whole-virus vaccines
IL243021B (en)	2018-04-30	A method for preparing multicyclic components
SI2634191T1 (sl)	2015-04-30	Postopek za pripravo derivatov tienopirimidindiona
GB0918679D0 (en)	2009-12-09	Influenza vaccine
ZA201101645B (en)	2011-11-30	Process for prodcution of vaccines
EP2488185A4 (en)	2013-06-05	INFECTIOUS TORQUE TENO VIRUS CLONE
GB2467215B (en)	2012-07-04	Burkholderia components vaccine
ZA201008125B (en)	2012-02-29	Inactivated live-attenuated bluetongue virus vaccine
GB0714489D0 (en)	2007-09-05	Process for preparing viral vaccine
ZA201203862B (en)	2013-01-30	Dna vaccine against virus of yellow fever
GB0920319D0 (en)	2010-01-06	HPV vaccine
GB0903910D0 (en)	2009-04-22	Vaccine production
HK1160799A (en)	2012-08-17	Influenza vaccines with reduced amounts of squalene